Aeglea BioTherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AGLE and buy or sell other stocks, ETFs, and their options commission-free!

About AGLE

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. 

CEO
Cameron Turtle, PhD
CEOCameron Turtle, PhD
Employees
65
Employees65
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2013
Founded2013
Employees
65
Employees65

AGLE Key Statistics

Market cap
708.02M
Market cap708.02M
Price-Earnings ratio
-4.50
Price-Earnings ratio-4.50
Dividend yield
—
Dividend yield—
Average volume
698.17K
Average volume698.17K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$40.49
52 Week high$40.49
52 Week low
$10.91
52 Week low$10.91
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.